U.S. Construction Stock News

Texas Capital Bancshares recently held a Non-Deal Roadshow on August 21, 2025, engaging with investors to discuss its business performance and outlook. The event highlighted ongoing market concerns about weak net interest income growth and poor net interest margin, which have raised questions about the company's profitability. We'll explore how these continuing worries around weak net interest income growth could shape Texas Capital Bancshares' future trajectory and investment...

If you have been following CG Oncology (CGON), the new attention from H.C. Wainwright might turn your head. The firm’s recent reiteration of a Buy rating, along with upbeat comments on progress for Cretostimogene, their promising therapy for hard-to-treat bladder cancer, has sparked a conversation among investors. H.C. Wainwright highlighted encouraging study results and the potential for more important data by year’s end, which could change how the market views CG Oncology’s future...

Earlier this week, Morgan Stanley declared regular dividends on several series of its preferred stock and completed a series of fixed-income offerings amounting to about US$10.93 million, with maturities ranging from 2028 to 2045 and fixed coupon rates between 4.00% and 5.15%. These capital management actions highlight Morgan Stanley’s ongoing focus on strengthening its balance sheet and providing steady returns to preferred shareholders amid evolving market expectations around interest...

Following dovish remarks from Federal Reserve Chair Jerome Powell at the Jackson Hole symposium, major US indices rebounded as expectations for potential interest rate cuts increased, easing market concerns over high borrowing costs. This shift in outlook particularly benefited rate-sensitive sectors such as real estate investment trusts, bringing renewed attention to the operating environment for companies like Ladder Capital. To see how prospects of lower interest rates may affect Ladder...

Krystal Biotech (KRYS) has just shifted its clinical development strategy in a way that is sure to catch the eye of investors weighing what to do next. The company reported encouraging results from its inhaled KB707 trial in non-small cell lung cancer, delivering a 36% objective response rate in a tough patient group. Following this data, Krystal secured a key FDA End of Phase 2 meeting, aimed at accelerating a registration path for this therapy. At the same time, they are pausing the...

In the past quarter, Sezzle reported a 74.2% year-over-year increase in gross merchandise volume, attributing this growth to heightened consumer engagement driven by product innovation and targeted marketing initiatives. This impressive expansion was underpinned by the company's ongoing investment in customer-focused features, which has helped increase both purchase frequency and the size of its active consumer base. We'll now explore how Sezzle's strong GMV growth and consumer-focused...

If you’re watching Analog Devices (ADI) after this week’s earnings report, you’re not alone. The company just logged quarterly results that beat expectations on both revenue and profit, powered by strong performance across its industrial, automotive, and communications segments. Even with ongoing geopolitical headwinds and a softer automotive market, management struck an upbeat note for the coming quarter by forecasting more revenue growth and improved margins. Investors received an added...

Thinking about what to do with your Energy Transfer shares or wondering if now is the time to jump in? You are definitely not alone. The stock has been on quite a journey, with one-year total returns at nearly 16.6%, and an impressive 85% over the past three years. Over the last five years, returns have approached 300%. Yet shares have dipped this year, pulling back about 11% year-to-date, and the price now sits at $17.51. This is a noticeable 30% discount to the average analyst target and an...

Environmental solutions may not be the first thing you think of when weighing stock picks, but recent developments could make Tetra Tech (TTEK) worth a closer look. The conversation around pollution control is heating up as global regulators clamp down on emissions. This is prompting surging demand for the very expertise Tetra Tech delivers. The renewed focus on cleaner technologies and compliance offers potential, especially for companies ready to capitalize on evolving regulations and...

If you are staring at Monolithic Power Systems stock and wondering whether it deserves a spot in your portfolio right now, you are not alone. Lately, the buzz around MPWR has been hard to miss, both from headline-grabbing market shifts and from those quietly impressive gains stacking up over the past few years. Despite a rocky patch recently, MPWR has posted a stellar 274% jump in the past 90 days and more than doubled over the last five years, suggesting some long-term growth potential. That...

In August 2025, Celanese Corporation reported its second quarter results, showing net income of US$199 million on US$2.53 billion in sales, alongside the launch of a new US$1.75 billion senior unsecured revolving credit facility extending liquidity until August 2030. This combination of rising earnings per share despite lower sales, plus refreshed financial flexibility, highlights management’s focus on both profitability and balance sheet strength. We’ll assess how Celanese’s new long-term...

Thinking about Union Pacific (UNP) and not quite sure whether you should hold, buy more, or take profits? You are not alone. Over the past few months, Union Pacific has had investors buzzing, especially following headlines that feel straight out of a finance thriller. First came the announced $85 billion acquisition of Norfolk Southern, something that could transform the freight railroad landscape. Not surprisingly, the news sent ripples through the industry and led many to reconsider what a...

Rumble Inc. recently reported its second quarter and six-month earnings for the period ended June 30, 2025, showing quarterly sales of US$25.08 million and a net loss of US$30.22 million. While quarterly net losses remained, the company achieved higher sales year-over-year and significantly reduced its six-month net loss compared to the previous year. We'll explore how reduced six-month net losses may influence Rumble's long-term investment narrative and future growth expectations. We've...

If you have been keeping an eye on Garmin (GRMN), today’s news might spark a fresh round of questions about where the stock goes from here. XTI Aerospace has just tapped Garmin’s G700 TXi flight deck for its flagship TriFan 600, an ambitious vertical takeoff and landing jet aimed at reinventing regional air travel. For Garmin, being chosen as the avionics provider for such a high-profile xVTOL project is more than a win. It is a stamp of validation in a rapidly evolving industry...

If you have been eyeing Restaurant Brands International, ticker QSR, and asking yourself whether now is the right time to get in or out, you are definitely not alone. In a market where quick service restaurants have seen plenty of ups and downs, QSR's share price has made its own statement recently. Over the past month, the stock has slipped by nearly 11%, extending its softness over the last quarter and year. On the other hand, when we zoom out, QSR has still logged a respectable 36% total...

If you are holding or eyeing shares of LifeStance Health Group (LFST), it has been a busy stretch. The appointment of Sarah Personette, a veteran in media and customer experience, to the board on August 22 signals a fresh breeze of expertise at the top. This comes as the company posts double-digit revenue growth and nudges its full-year outlook higher. However, just as optimism takes center stage, heavyweight insiders and major shareholders have unloaded large stakes. This suggests a ripple...

The Toro Company (TTC) is turning heads this week following the appointment of Edric C. Funk as its new president and chief operating officer. With nearly three decades at Toro, Funk’s track record, ranging from driving technology acquisitions to leading key business segments, signals the company’s continued push into smart solutions and innovation. For investors, leadership shifts like this often act as catalysts, shaking up market sentiment and sparking fresh takes on a company’s growth...

If you are sizing up Barrick Mining and wondering if it is time to buy, sell, or hold, you are not alone. With the stock up over 21% in the last 30 days and surging more than 37% in the past three months, Barrick has been catching the eye of both seasoned investors and newcomers alike. While the gold market's momentum and improving earnings have given the share price a lift, there is always the question of whether the stock's run has left it expensive or if there is more growth ahead. When we...

Euronet Worldwide recently completed an US$850 million offering of 0.625% senior unsecured convertible notes due October 2030, issued under Rule 144A and priced at par. This sizable convertible bond issuance introduces potential future equity dilution and reflects Euronet’s appetite to access capital for ongoing digital payments growth initiatives. We’ll now examine what Euronet’s US$850 million convertible notes could mean for its long-term digital strategy and investment narrative. Rare...

In recent days, Chairman & CEO Randall Stuewe sold 62,500 shares of Darling Ingredients, and the company launched Nextida, a joint venture focused on health and wellness markets. This activity unfolds as analysts express caution over regulatory uncertainty impacting renewable diesel margins, highlighting shifts in both leadership actions and business strategy. We’ll explore how the CEO’s share sale may influence confidence in Darling Ingredients’ evolving investment narrative. Trump's oil...

Earlier this month, Atmus Filtration Technologies announced that its Board of Directors approved a quarterly cash dividend increase to US$0.055 per common share, up 10% from the previous dividend, payable on September 10, 2025 to shareholders of record as of August 26, 2025. This boost in the company's dividend payout reflects management's confidence in financial health and commitment to providing greater returns to shareholders. We will explore how this dividend increase may influence...

If you’ve been watching Ligand Pharmaceuticals (LGND) lately, you know it has just wrapped up a $400 million convertible note offering, with new senior unsecured notes coming due in 2030. This financing move brings names like Citigroup, BofA Securities, and Stifel as co-lead underwriters, signaling that the company is making deliberate efforts to bolster its financial flexibility. For investors, a convertible bond deal of this size can indicate that Ligand is seeking resources for its...

If you are eyeing MSCI and wondering whether to add it to your portfolio, you are not alone. The stock has had its share of twists and turns lately. In just the last month, MSCI shares climbed over 8%, a move that may have caught the attention of growth-oriented investors. Even with some choppy action earlier this year, as shown by its recent year-to-date decline of almost 4%, the company’s long-term run remains impressive, with a five-year return topping 61%. Clearly, the broader market...

If you have been watching Cheniere Energy (ticker: LNG), you are not alone. The stock’s story has been regularly turning heads, and recent moves on the chart have only made it more interesting for investors trying to decide whether to buy, sell, or hold. Over the past month, Cheniere Energy’s share price has climbed over 6%, with year-to-date gains at nearly 8%. Go back a year, and you are looking at about a 30% total return. In fact, looking further back, the five-year total return clocks in...